↓ Skip to main content

Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies

Overview of attention for article published in BMC Cancer, November 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
62 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Temozolomide sensitivity of malignant glioma cell lines – a systematic review assessing consistencies between in vitro studies
Published in
BMC Cancer, November 2021
DOI 10.1186/s12885-021-08972-5
Pubmed ID
Authors

Michael T. C. Poon, Morgan Bruce, Joanne E. Simpson, Cathal J. Hannan, Paul M. Brennan

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 62 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 21%
Student > Master 12 19%
Researcher 10 16%
Student > Bachelor 6 10%
Student > Doctoral Student 2 3%
Other 7 11%
Unknown 12 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 21%
Chemistry 8 13%
Medicine and Dentistry 7 11%
Neuroscience 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Other 11 18%
Unknown 15 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2021.
All research outputs
#6,871,350
of 25,042,800 outputs
Outputs from BMC Cancer
#1,726
of 8,856 outputs
Outputs of similar age
#143,444
of 516,065 outputs
Outputs of similar age from BMC Cancer
#29
of 195 outputs
Altmetric has tracked 25,042,800 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 8,856 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 516,065 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.